Hermetica Superfood Encyclopedia
The Short Answer
Phyllanthus amarus contains hepatoprotective lignans (phyllanthin, hypophyllanthin), tannins (geraniin, corilagin), and flavonoids (quercetin, rutin) that inhibit NF-κB signaling, downregulate TNF-α and IL-1β, and block CCl4-induced hepatic oxidative stress and fibrosis via caspase-3-mediated pathways. Preclinical evidence demonstrates that the lignan phyllanthin suppresses hepatic fibrosis markers and that chicken liver enzyme studies confirmed no hepatotoxicity at doses of 250–1,000 mg/mL over 14 days, though no human randomized controlled trials have yet confirmed these hepatoprotective effects.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordFisoa Phyllanthus amarus benefits
Fisoa — botanical close-up
Health Benefits
**Hepatoprotection**
Phyllanthin and hypophyllanthin suppress CCl4-induced hepatic oxidative stress and fibrosis; in vitro data show induction of HepG2 apoptosis via caspase-3, and animal studies confirm preservation of normal ALT/AST/ALP ranges.
**Anti-inflammatory Activity**
Ethanolic and aqueous extracts inhibit TNF-α, IL-1β, PGE2, and COX-2 expression, and downregulate NF-κB, TLR4, and MyD88 signaling cascades in LPS-stimulated macrophage models.
**Antioxidant Defense**: DPPH radical scavenging activity reaches up to 74
4% inhibition, attributed to phenolic compounds including geraniin, corilagin, quercetin, and rutin, which quench reactive oxygen species and protect cellular membranes.
**Antimicrobial and Antiparasitic Effects**
Aqueous and ethanolic leaf extracts demonstrate activity against bacterial pathogens and reduce trypanosomal parasitaemia in rodent models, mediated by tannins and alkaloids disrupting pathogen membrane integrity.
**Antihypertensive Potential**
Aqueous extracts have been shown in rodent studies to lower blood pressure, likely through modulation of smooth muscle tone and prostaglandin biosynthesis via fatty acid constituents including palmitic acid and phytol.
**Anticancer/Cytotoxic Signaling**
Phyllanthin triggers apoptosis in HepG2 liver cancer cells via caspase-3 activation and modulation of Akt and MAPK (JNK, ERK, p38) pathways, suggesting potential adjunctive oncological relevance pending clinical investigation.
**Immunomodulation**
Downregulation of NF-κB, MyD88, and TLR4 in macrophage models indicates broad immunomodulatory capacity that may help temper excessive inflammatory responses associated with chronic liver disease and infection.
Origin & History
Natural habitat
Phyllanthus amarus is a small annual herb native to tropical and subtropical regions, including the Pacific Islands, South Asia, West Africa, and the Americas, where it thrives in disturbed soils, roadsides, and cultivated fields up to 1,000 meters elevation. In Samoa and broader Polynesia, it grows as a common weed and is harvested from wild populations rather than cultivated. The plant prefers warm, humid climates with well-drained soils and reaches 10–60 cm in height, producing small, oblong leaves arranged in two rows along slender branches.
“In Samoan traditional medicine, Fisoa (Phyllanthus amarus) holds an established role as a remedy for liver disorders, with healers administering leaf decoctions to address jaundice and general hepatic weakness, reflecting a broader Pacific Islander pharmacopoeia that emphasizes plant-based hepatic tonics. Across South and Southeast Asia, the plant — known variously as bhumyamalaki in Ayurveda and Stone Breaker in Caribbean herbal tradition — has been employed for millennia to treat kidney stones, viral hepatitis, and urinary infections, appearing in classical Ayurvedic texts such as the Charaka Samhita. In West African ethnomedicine, whole-plant preparations are used for malaria, gonorrhea, and hypertension, demonstrating the broad geographic reach of its traditional applications. The consistency of hepatoprotective use across culturally distinct populations — Polynesian, South Asian, African, and Amazonian — represents a striking example of ethnopharmacological convergence that has motivated modern phytochemical investigation.”Traditional Medicine
Scientific Research
Research on Phyllanthus amarus is predominantly preclinical, consisting of in vitro cell culture experiments and small animal studies, with no published human randomized controlled trials identified in the current literature base. Animal studies include rodent models demonstrating reduced trypanosomal parasitaemia with ethanol extract and antihypertensive effects with aqueous extract, and a poultry hepatotoxicity study at 250–1,000 mg/mL over 14 days confirming normal hepatic enzyme profiles (AST approximately 33–56 IU/L). A pharmacokinetic interaction study identified a 3.9-fold increase in midazolam Cmax and 9.6-fold increase in AUC following co-administration, pointing to clinically significant CYP3A inhibition. The overall evidence base is characterized by methodological heterogeneity, small or unspecified sample sizes, and absence of Phase I–III human trials, meaning all hepatoprotective and anti-inflammatory claims remain unconfirmed in humans.
Preparation & Dosage
Traditional preparation
**Traditional Samoan Decoction**
5–10 g) boiled in water and consumed as a tea; preparation method mirrors use across Pacific Islander and South Asian traditions for liver and urinary complaints
Fresh or dried leaves (approximately .
**Aqueous Extract (Tea/Infusion)**
Whole dried herb steeped in hot water; no standardized human dose established; used empirically in traditional settings.
**Ethanolic Leaf Extract**
000 mg/mL concentrations, which are not directly translatable to human supplemental doses
Research preparations employ 70–80% ethanol extractions; animal studies used 250–1,.
**n-Hexane Extract**
000 mg/mL; not a form typically available as a consumer supplement
Used in phytochemical and toxicity research at 250–1,.
**Standardized Supplements**
No internationally recognized standardization percentage for phyllanthin or hypophyllanthin content exists; products claiming standardization should be evaluated with caution.
**Timing**
Traditional use involves consumption 1–2 times daily with meals; no evidence-based timing guidance for supplemental use is available.
**Dose Caution**
No safe or effective human dose range has been established through clinical trials; caution is warranted especially in individuals taking CYP3A4-metabolized medications.
Nutritional Profile
Phyllanthus amarus leaves contain a complex matrix of bioactive phytochemicals rather than significant macronutrient content. Key lignans include phyllanthin and hypophyllanthin (concentrations vary by extraction but are detectable by LC-MS/MS), and tannins geraniin, amariin, and corilagin are among the dominant polyphenols. Flavonoids quercetin and rutin contribute to the antioxidant phenolic pool, while the terpenes lupeol and oleanolic acid represent the principal triterpene fraction. Fatty acid profiling of ethanolic extracts identifies palmitic acid (11.8%), dioctyl ester (10.1%), 9-hexadecenal (9.0%), and 2,13-octadecadiene-1-ol (8.2%) as major constituents by relative percentage. The lipophilic fraction includes phytol and vitamin E (tocopherol), and alkaloid content contributes to the plant's antimicrobial properties. Bioavailability of polyphenolic compounds is enhanced by 80% ethanolic extraction relative to aqueous preparations, likely due to increased solubility of lignans and lipid-soluble terpenes.
How It Works
Mechanism of Action
The hepatoprotective lignan phyllanthin blocks CCl4-induced lipid peroxidation and oxidative hepatocyte damage by quenching reactive oxygen species and preserving mitochondrial membrane integrity, while simultaneously inducing apoptosis in aberrant hepatocytes via caspase-3 activation. Anti-inflammatory activity is driven by downregulation of the NF-κB/TLR4/MyD88 signaling axis, resulting in reduced transcription of COX-2, TNF-α, IL-1β, and PGE2 in macrophages exposed to lipopolysaccharide. Tannins such as geraniin and corilagin contribute antioxidant effects through direct radical scavenging (DPPH IC50 consistent with up to 74.4% inhibition) and chelation of redox-active metal ions, while flavonoids quercetin and rutin modulate MAPK pathways (JNK, ERK, p38) to attenuate inflammatory gene expression. Additionally, the plant inhibits intestinal and hepatic CYP3A4 enzyme activity, substantially altering the pharmacokinetics of co-administered CYP3A substrates such as midazolam, increasing their systemic exposure by as much as 9.6-fold in AUC.
Clinical Evidence
No human clinical trials evaluating Fisoa (Phyllanthus amarus) for liver disease or any other indication have been identified in the peer-reviewed literature at this time. The most quantitatively informative preclinical data derive from a 14-day poultry study using n-hexane extracts at 250–1,000 mg/mL, which documented stable hepatic enzyme markers (ALT, AST, ALP, total protein) without significant deviation from control values, suggesting low acute hepatotoxicity in that model. A pharmacokinetic study documenting CYP3A inhibition — with midazolam AUC increasing 9.6-fold and clearance reduced by 12% — represents the most clinically actionable finding, carrying direct implications for drug interaction risk. Confidence in therapeutic efficacy for liver conditions in humans is low pending adequately powered, placebo-controlled clinical trials.
Safety & Interactions
Phyllanthus amarus has demonstrated an absence of acute hepatotoxicity in poultry studies at doses of 250–1,000 mg/mL over 14 days, with liver enzyme markers remaining within normal ranges, and no toxicity has been reported in Drosophila models, supporting a generally favorable acute safety profile in non-human models. The most critical safety concern is potent inhibition of CYP3A4, which increases systemic exposure of CYP3A substrates — including midazolam, statins, calcineurin inhibitors, and certain antiretrovirals — by up to 9.6-fold in AUC, representing a clinically significant drug interaction risk that warrants avoidance in polypharmacy contexts. No formal contraindications have been established, but use during pregnancy and lactation cannot be considered safe given the complete absence of human safety data and the presence of biologically active alkaloids and tannins that may affect uterine tone or neonatal hepatic enzyme maturation. Maximum safe human doses have not been determined through clinical research, and individuals with pre-existing liver disease, renal impairment, or those taking narrow-therapeutic-index medications should seek physician guidance before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Phyllanthus amarusStone BreakerBhumyamalakiChanca PiedraGale of Wind
Frequently Asked Questions
What is Fisoa used for in Samoan traditional medicine?
In Samoan traditional medicine, Fisoa (Phyllanthus amarus) is primarily used as a decoction of fresh or dried leaves to treat liver disorders, including conditions associated with jaundice and hepatic dysfunction. Healers prepare the remedy by boiling leaves in water and administering it orally, drawing on a tradition of hepatic plant medicine shared across Pacific Island cultures. While this use aligns with preclinical evidence showing hepatoprotective activity from lignans like phyllanthin, no human clinical trials have yet confirmed efficacy for liver conditions in Samoan or other populations.
What are the active compounds in Phyllanthus amarus?
Phyllanthus amarus contains over 15–20 identified bioactive compounds, with the most pharmacologically studied being the lignans phyllanthin, hypophyllanthin, and niranthin, and the hydrolyzable tannins geraniin, amariin, and corilagin. Flavonoids quercetin and rutin contribute significant antioxidant and anti-inflammatory activity, while the triterpenes lupeol and oleanolic acid provide additional anti-inflammatory and potential anticancer properties. The fatty acid composition of ethanolic extracts is dominated by palmitic acid (11.8%), and the lipophilic fraction includes phytol and vitamin E, with concentrations varying considerably depending on extraction solvent and plant part used.
Does Phyllanthus amarus interact with medications?
Yes, Phyllanthus amarus is a significant inhibitor of the CYP3A4 enzyme, which is responsible for metabolizing approximately 50% of all pharmaceutical drugs. In a pharmacokinetic study, co-administration with midazolam (a CYP3A4 substrate) resulted in a 3.9-fold increase in peak plasma concentration (Cmax) and a 9.6-fold increase in total drug exposure (AUC), with clearance reduced by 12%. Patients taking CYP3A4-metabolized drugs — including statins, immunosuppressants, benzodiazepines, certain antiretrovirals, and calcium channel blockers — should avoid Phyllanthus amarus without medical supervision due to the risk of elevated drug levels and toxicity.
Is Fisoa safe to take, and what are the side effects?
Preclinical data from a 14-day poultry study using n-hexane extracts at 250–1,000 mg/mL showed no hepatotoxic effects, with liver enzymes AST, ALT, ALP, and total protein remaining within normal ranges, and no toxicity was observed in Drosophila models. The herb is generally regarded as safe in traditional use contexts, but no formal human safety trials have been conducted, meaning the full side effect profile in humans is unknown. The most established risk is the pharmacokinetic drug interaction via CYP3A4 inhibition, and use during pregnancy or lactation is inadvisable given the absence of safety data in these populations.
What is the recommended dose of Phyllanthus amarus?
No standardized or evidence-based human dose for Phyllanthus amarus has been established through clinical trials, making it impossible to recommend a specific supplemental dose with confidence. Animal and laboratory studies have used extract concentrations of 250–1,000 mg/mL, which are research concentrations not directly translatable to human dosing. Traditional Samoan and Ayurvedic preparations typically involve consuming a tea or decoction made from approximately 5–10 g of dried leaves once or twice daily, but individuals should consult a healthcare provider before use, particularly if taking prescription medications that are CYP3A4 substrates.
What does clinical research show about Phyllanthus amarus for liver health?
Clinical and animal studies demonstrate that phyllanthin and hypophyllanthin in Phyllanthus amarus suppress hepatic oxidative stress and fibrosis induced by toxins like carbon tetrachloride (CCl4). Research shows the herb preserves normal liver enzyme ranges (ALT, AST, ALP) and triggers apoptosis in liver cancer cells via caspase-3 activation in laboratory models. However, most evidence is from animal studies and in vitro research, with limited large-scale human clinical trials currently available.
How does Phyllanthus amarus work as an anti-inflammatory supplement?
Phyllanthus amarus extracts inhibit multiple inflammatory pathways by suppressing TNF-α, IL-1β, PGE2, and COX-2 expression while downregulating NF-κB and TLR4 signaling. Both ethanolic and aqueous extracts of the herb demonstrate these immunomodulatory effects in laboratory studies. This multi-target anti-inflammatory mechanism may contribute to its traditional use for inflammatory and immune-related conditions.
Is Phyllanthus amarus more effective in extract form or whole herb form?
Standardized extracts of Phyllanthus amarus typically concentrate active compounds like phyllanthin and hypophyllanthin, potentially offering more consistent potency than whole herb preparations. Both ethanolic and aqueous extracts show bioactivity in research, though ethanolic extracts may provide broader compound extraction. The optimal form depends on intended use and individual absorption, though extract forms generally allow for more controlled dosing of active constituents.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w fisoa-phyllanthus-amarus curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
